Olaf Stuve

35PUBLICATIONS
68CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMarine engineeringRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 21, 2026
Induced pluripotent stem cell treatment for microglia replacement in progressive MS.

|Apr 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis.

|Feb 23, 2026
Vedolizumab and the gut-CNS axis in multiple sclerosis: considering T cell licensing pathways.

Afsaneh Shirani, Olaf Stuve

|Jan 03, 2026
Clinical and radiological outcomes of directed treatment transitions from Gilenya® to generic fingolimod.

Mahi A Patel, Tom G Punnen, Kevin S Shan

|Dec 15, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.

Rebecca I Spain, M Mateo Paz Soldán, Mark S Freedman

|Nov 21, 2025
Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System.

Afsaneh Shirani, Samuel A Goldlust, Olaf Stuve

Pageof 6

Frequent Collaborators

8 joint publications

Afsaneh Shirani

4 joint publications

Navid Manouchehri

3 joint publications

Amber Salter

2 joint publications

Natalia Gonzalez Caldito